AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vriglib-M Tablet SR

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview Vriglib-M Tablet SR

DiabetaComb SR tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. This medication helps regulate blood glucose levels. DiabetaComb SR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and carry a rapid-acting glucose source, such as sugary snacks or juice. Alcohol consumption should be minimized due to its potential to lower blood sugar. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women must consult their doctor. Regular blood glucose monitoring is essential, and your physician may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Vriglib-M Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Vriglib-M Tablet SR

Managing type 2 diabetes

Major Benefits of Vriglib-M Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vriglib-M Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with a meal.

Common Side effects of Vriglib-M Tablet SR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Flatulence

How to use Vriglib-M Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for Vriglib-M SR Tablets. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

How Vriglib-M Tablet SR works:

Vriglib-M SR tablets contain a dual-action formulation of glibenclamide and metformin, both medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Vriglib-M SR tablets.

PregnancyPregnancySAFE IF PRESCRIBED

The extended-release Vriglib-M tablet is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, human data on this are scarce.

Breast feedingBreast feedingCAUTION

Extended-release Vriglib-M tablets require careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Vriglib-M Tablet SR on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Vriglib-M Tablet SR due to potential safety concerns. A physician's consultation is recommended.

LiverLiverCAUTION

Exercise caution when prescribing Vriglib-M Tablet SR to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver disease, initiate Vriglib-M Tablet SR therapy with a reduced initial dose; its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Vriglib-M Tablet SR :

Should you forget a Vriglib-M Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vriglib-M Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vriglib-M Tablet SR

Vriglib-M SR tablets combine glibenclamide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, occurs when the body doesn't produce enough insulin or the insulin it produces is ineffective. This leads to elevated blood glucose, causing serious health issues. Symptoms include excessive urination, thirst, and hunger. Untreated, type 2 diabetes can result in long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and increased heart disease risk.
Vriglib-M Tablet SR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Vriglib-M Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Prolonged Vriglib-M Tablet SR use can interfere with vitamin B12 absorption, potentially leading to deficiency. Untreated deficiency may cause anemia, nerve damage (tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Vriglib-M Tablet SR is contraindicated in patients with known hypersensitivity to its components or excipients, those with moderate to severe renal impairment, and those with underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Vriglib-M Tablet SR and alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vriglib-M Tablet SR
94
MRP 109
13% off